High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia

Acta Tropica

Volumn 119, Issue 1, 2011, Pages 23-29

  Restrepo, Eliana ^a   Imwong, Mallika ^b   Rojas, Winston ^a   Carmona Fonseca, Jaime ^a   Maestre, Amanda ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Colombia; Malaria; Microsatellites; Plasmodium vivax; Polymorphism; Recurrence; Relapse

Indexed keywords

GENETIC STRUCTURE; GENETIC VARIATION; GENOTYPE; MALARIA; PARASITE; POLYMORPHISM;

ALLELE; ARTICLE; CLINICAL ARTICLE; CLONAL VARIATION; COLOMBIA; CONTROLLED STUDY; ENDEMIC DISEASE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC DISTANCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MICROSATELLITE MARKER; NONHUMAN; PLASMODIUM VIVAX; RECURRENT INFECTION;

ALLELES; BLOOD; COLOMBIA; DNA, PROTOZOAN; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETICS, POPULATION; HAPLOTYPES; HETEROZYGOTE; HUMANS; MALARIA, VIVAX; MICROSATELLITE REPEATS; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

COLOMBIA;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 79957602924     PISSN: 0001706X     EISSN: 0001706X     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.03.012     Document Type: Article

References (51)

1. Adak T., Sharma V., Orlov V. Studies on the Plasmodium vivax relapse pattern in Delhi, India. Am. J. Trop. Med. Hyg. 1998, 59:175-179.
2. Adak T., Valecha N., Sharma V. Plasmodium vivax polymorphism in a clinical drug trial. Clin. Diagn. Lab. Immunol. 2001, 8:891-894.
3. Alvarez G., Piñeros J., Tobon A., Rios A., Maestre A., Blair S., Carmona-Fonseca J. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia. Am. J. Trop. Med. Hyg. 2006, 75:605-609.
4. Baird J., Basri H., Purnomo E., Bangs M., Subianto B., Patchen L., Hoffman S. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 1991, 44:547-552.
5. Bandelt H., Forster P., Röhl A. Median-joining networks for inferring intraspecific phylogenies. Mol. Biol. Evol. 1999, 16:37-48.
6. Carlton J., Adams J., Silva J., Bidwell S., Lorenzi H., Caler E., Crabtree J., Angiuoli S., Merino E., Amedeo P., Cheng Q., Coulson R., Crabb B., Del Portillo H., Essien K., Feldblyum T., Fernandez-Becerra C., Gilson P., Gueye A., Guo X., Kang'a S., Kooij T., Korsinczky M., Meyer E., Nene V., Paulsen I., White O., Ralph S., Ren Q., Sargeant T., Salzberg S., Stoeckert C., Sullivan S., Yamamoto M., Hoffman S., Wortman J., Gardner M., Galinski M., Barnwell J., Fraser-Liggett C. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
7. Carmona-Fonseca J. La malaria en Colombia, Antioquia y las Zonas de Urabá y Bajo Cauca: Panorama Para Interpretar la Falla Terapéutica Antimalárica Parte 1 2003, vol. 16. Iatreia, pp. 299-318.
8. Carmona-Fonseca J. La Malaria en Colombia, Antioquia y las Zonas de Urabá y Bajo Cauca: Panorama Para Interpretar la Falla Terapéutica Antimalárica Parte 2 2004, vol. 17. Iatreia, pp. 34-53.
9. Carmona-Fonseca J., Alvarez G., Maestre A. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment. Am. J. Trop. Med. Hyg. 2009, 80:188-193.
10. Carmona-Fonseca J., Álvarez H., Blair S. Malaria por Plasmodium vivax: curación del ataque agudo con tres dosis diferentes de primaquina y dosis fija de cloroquina. Antioquia, Colombia, 2003-2004. Biomedica 2006, 26:353-365.
11. Carmona-Fonseca J., Maestre A. Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days. Acta Trop. 2009, 112:188-192.
12. Carmona-Fonseca J., Uscategui R., Correa A. Malaria vivax en niños: aspectos clínicos y respuesta a la cloroquina. Colomb. Med. 2008, 39:364-377.
13. Cristiano F., Pérez M., Nicholls R., Guerra A. Polymorphism in the Plasmodium vivax msp 3: gene in field samples from Tierralta, Colombia. Mem. Inst. Oswaldo Cruz. 2008, 103:493-496.
14. Chen N., Auliff A., Rieckmann K., Gatton M., Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 2007, 195:934-941.
15. Dalla Martha R., Tada M., Ferreira R., Da Silva L., Wunderlich G. Microsatellite characterization of Plasmodium falciparum from symptomatic and non-symptomatic infections from the Western Amazon reveals the existence of non-symptomatic infection-associated genotypes. Mem. Inst. Oswaldo Cruz. 2007, 102:293-298.
16. de Santana Filho F., Arcanjo A., Chehuan Y., Costa M., Martinez-Espinosa F., Vieira J., Barbosa M., Alecrim W., Alecrim M. Chloroquine-resistant Plasmodium vivax. Brazilian Amazon. Emerg. Infect. Dis. 2007, 13:1125-1126.
17. DSSA (Dirección Seccional de Salud de Antioquia), 2007. Malaria en Antioquia, sus regiones y municipios. 2006. (Consulted 27.08.08). http://www.dssa.gov.co/dowload/archivoseventos_2007/EnotificacionSPVer2006-2.xls.
18. DSSA (Dirección Seccional de Salud de Antioquia), 2008. Malaria en Antioquia, sus regiones y municipios. 2007. (Consulted 01.06.09). http://www.dssa.gov.co/dowload/descargas2008/EVENTOS_DE_INTERES_EN_SALUD_PUBLICA_2007.xls.
19. DSSA (Dirección Seccional de Salud de Antioquia), 2010. Incidencia de malaria en Antiouia, por municipios y regiones, 2000-2009. (Consulted 20.10.10). http://www.dssa.gov.co/index.php/estadisticas/eventos-de-salud-publica.
20. Espinosa A., Sierra A., Barrero C., Cepeda L., Cantor E., Lombo T., Guzman F., Avila S., Patarroyo M. Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments. Vaccine 2003, 21:1033-1043.
21. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol. Bioinform. Online 2005, 1:47-50.
22. Ferreira M., Karunaweera N., Da Silva-Nunes M., Da Silva N., Wirth D., Hartl D. Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia. J. Infect. Dis. 2007, 195.
23. Garavelli P., Corti E. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:128.
24. Garg M., Gopinathan N., Bodhe P., Kshirsagar N. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:656-657.
25. Garzon-Ospina D., Romero-Murillo L., Patarroyo M. Limited genetic polymorphism of the Plasmodium vivax low molecular weight rhoptry protein complex in the Colombian population. Infect. Genet. Evol. 2010, 10:261-267.
26. Gomez J., Mcnamara D., Bockarie M., Baird J., Carlton J., Zimmerman P. Identification of a polymorphic Plasmodium vivax microsatellite marker. Am. J. Trop. Med. Hyg. 2003, 69:377-379.
27. Gutierrez A., Vicini J., Patarroyo M., Murillo L., Patarroyo M. Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates. Exp. Parasitol. 2000, 95:215-219.
28. Havryliuk T., Ferreira M. A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences. Mem. Inst. Oswaldo Cruz. 2009, 104:67-73.
29. Hernandez-Martinez M., Escalante A., Arevalo-Herrera M., Herrera S. Antigenic diversity of the Plasmodium vivax circumsporozoite protein in parasite isolates of Western Colombia. Am. J. Trop. Med. Hyg. 2011, 84:51-57.
30. Imwong M., Nair S., Pukrittayakamee S., Sudimack D., Williams J., Mayxay M., Newton P., Kim J., Nandy A., Osorio L., Carlton J., White N., Day N., Anderson T. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America. Int. J. Parasitol. 2007, 37:1013-1022.
31. Imwong M., Snounou G., Pukrittayakamee S., Tanomsing N., Kim J., Nandy A., Guthmann J., Nosten F., Carlton J., Looareesuwan S., Nair S., Sudimack D., Day N., Anderson T., White N. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 2007, 195:927-933.
32. Imwong M., Sudimack D., Pukrittayakamee S., Osorio L., Carlton J., Day N., White N., Anderson T. Microsatellite variation, repeat array length, and population history of Plasmodium vivax. Mol. Biol. Evol. 2006, 23:1016-1018.
33. Karunaweera N., Ferreira M., Hartl D., Wirth D. Fourteen polymorphic microsatellite DNA markers for the human malaria parasite Plasmodium vivax. Mol. Ecol. Notes 2007, 7:172-175.
34. Karunaweera N., Ferreira M., Munasinghe A., Barnwell J., Collins W., King C., Kawamoto F., Hartl D., Wirth D. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Gene 2008, 410:105-112.
35. Kyaw M., Oo M., Lwin M., Zin T., Aye K., Yin N. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 1993, 87:687.
36. Liu S., Mu J., Jiang H., Su X. Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping. Am. J. Trop. Med. Hyg. 2008, 79:178-184.
37. Lwanga S., Lameshow S. Determinación del tamaño muestral en los estudios sanitarios 1991, Manual prático, OMS, Ginebra.
38. Maestre A., Sunil S., Ahmad G., Mohmmed A., Echeverri M., Corredor M., Blair S., Chauhan V., Malhotra P. Inter-allelic recombination in the Plasmodium vivax merozoite surface protein 1 gene among Indian and Colombian isolates. Malar. J. 2004, 3:4.
39. Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma-Sabai, Myint-Oo Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:307-308.
40. Martinez P., Suarez C., Gomez A., Cardenas P., Guerrero J., Patarroyo M. High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Infect. Genet. Evol. 2005, 5:354-361.
41. Murphy G., Basri H., Purnomo E., Andersen E., Bangs M., Gorden J., Sorensen K., Mount M., Purwokusumo A., Harjosuwarno S., Hoffman S. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993, 341:96-100.
42. Orjuela-Sanchez P., da Silva N., da Silva-Nunes M., Ferreira M. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Am. J. Trop. Med. Hyg. 2009, 81:961-968.
43. Orjuela-Sanchez P., Karunaweera N., Da Silva-Nunes M., Da Silva N., Scopel K., Gonçalves R., Amaratunga C., Sá J., Socheat D., Fairhust R., Gunawardena S., Thavakodirasah T., Galapaththy G., Abeysinghe R., Kawamoto F., Wirth D., Ferreira M. Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies. BMC Genet. 2010, 11:65.
44. Phillips E., Keystone J., Kain K. Failure of combined chloroquine and high dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin. Infect. Dis. 1996, 23:1171-1173.
45. Rezende A., Tarazona-Santos E., Fontes C., Souza J., Couto A., Carvalho L., Brito C. Microsatellite loci: determining the genetic variability of Plasmodium vivax. Trop. Med. Int. Health 2010, 15:18-26.
46. Ruebush T., Zegarra J., Cairo J., Andersen E., Green M., Pillai D., Marquiño W., Huilca M., Arevalo E., Garcia C., Solary L., Kain K. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am. J. Trop. Med. Hyg. 2003, 69:548-552.
47. Russell B., Udomsangpetch R., Rieckmann K., Kotecka B., Coleman R., Sattabongkot J. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob. Agents. Chemother. 2003, 47:170-173.
48. Snounou G., Singh B. Nested PCR analysis of Plasmodium parasites. Methods Mol. Med. 2002, 72:189-203.
49. Soto J., Toledo J., Gutierrez P., Luzz M., Llinas N., Cedeño N., Dunne M., Berman J. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am. J. Trop. Med. Hyg. 2001, 65:90-93.
50. Van den Eede P., Soto-Calle V., Delgado C., Gamboa D., Grande T., Rodriguez H., Llanos-Cuentas A., Anne J., D'Alessandro U., Erhart A. Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study. PLoS One 2011, 6:e16257.
51. World Health Organization (WHO), 2006. Guidelines for the Treatment of Malaria. 368 Document WHO/HTM/MAL/2006. 1108. WHO, Geneva.